{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:22:57Z","timestamp":1762291377468,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","award":["359-2020-2655"],"award-info":[{"award-number":["359-2020-2655"]}],"id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jocn.2025.111603","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T01:06:49Z","timestamp":1756948009000},"page":"111603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Correlations between surface marker patterns in meningiomas, prognosis and location"],"prefix":"10.1016","volume":"141","author":[{"given":"Nadja","family":"Blum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Skyrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiel","family":"Orrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"F\u00f6rander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey V.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeppe Haslund","family":"Vinding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Daniela","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9463-1919","authenticated-orcid":false,"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jocn.2025.111603_b0005","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2025.111603_b0010","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2025.111603_b0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bpa.12174","article-title":"Mitotic index is an independent predictor of recurrence-free survival in meningioma","volume":"25","author":"Olar","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jocn.2025.111603_b0025","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.wneu.2017.12.035","article-title":"Differential tumor progression patterns in skull base versus non-skull base meningiomas: a critical analysis from a long-term follow-up study and review of literature","volume":"112","author":"Savardekar","year":"2018","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.jocn.2025.111603_b0035","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1586\/14737175.6.11.1671","article-title":"Diagnostic and molecular pathology of meningiomas","volume":"6","author":"Hartmann","year":"2006","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0040","first-page":"204","article-title":"Immunohistochemistry in the diagnosis of neoplasms of the central nervous system","volume":"17","author":"Morrison","year":"2000","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3171\/jns.1997.86.1.0113","article-title":"Progesterone and estrogen receptors in meningiomas: prognostic considerations","volume":"86","author":"Hsu","year":"1997","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.jocn.2025.111603_b0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3171\/jns.2006.105.2.163","article-title":"Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas","volume":"105","author":"Pravdenkova","year":"2006","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.jocn.2025.111603_b0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","article-title":"The Ki-67 Proliferation index as a marker of time to recurrence in intracranial meningioma","volume":"87","author":"Mirian","year":"2020","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.jocn.2025.111603_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","article-title":"Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis","volume":"91","author":"Mirian","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2025.111603_b0070","article-title":"Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas","volume":"1\u201310","author":"Youngblood","year":"2019","journal-title":"J Neurosurg"},{"issue":"6123","key":"10.1016\/j.jocn.2025.111603_b0075","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jocn.2025.111603_b0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.wneu.2011.05.015","article-title":"Long-term 25-year follow-up of surgically treated parasagittal meningiomas","volume":"76","author":"Pettersson-Segerlind","year":"2011","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","article-title":"Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients A multivariate analysis","volume":"26","author":"Jaaskelainen","year":"1986","journal-title":"Surg Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jocn.2013.06.008","article-title":"An audit of immunohistochemical marker patterns in meningioma","volume":"21","author":"Baxter","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2025.111603_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104303","article-title":"Comprehensive proteomic analysis reveals distinct functional modules associated with skull base and supratentorial meningiomas and perturbations in collagen pathway components","volume":"246","author":"Mukherjee","year":"2021","journal-title":"J Proteomics"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/2015.6.JNS15591","article-title":"Genomic landscape of intracranial meningiomas","volume":"125","author":"Bi","year":"2016","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.wneu.2013.01.095","article-title":"Meningiomas engaging major venous sinuses","volume":"81","author":"Mathiesen","year":"2014","journal-title":"World Neurosurg"},{"issue":"20","key":"10.1016\/j.jocn.2025.111603_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205038","article-title":"Long-term follow-up, treatment strategies, functional outcome, and health-related quality of life after surgery for WHO grade 2 and 3 intracranial meningiomas","volume":"14","author":"Pettersson-Segerlind","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.jocn.2025.111603_b0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10495-006-0001-4","article-title":"Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas","volume":"12","author":"Konstantinidou","year":"2007","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI116165","article-title":"Expression of the vascular permeability factor\/vascular endothelial growth factor gene in central nervous system neoplasms","volume":"91","author":"Berkman","year":"1993","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1015765613544","article-title":"Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness","volume":"57","author":"Nordqvist","year":"2002","journal-title":"J Neurooncol"},{"issue":"13","key":"10.1016\/j.jocn.2025.111603_b0130","first-page":"2611","article-title":"A high ratio of insulin-like growth factor II\/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas","volume":"57","author":"Nordqvist","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2025.111603_b0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-804280-9.00010-X","article-title":"Vascularity of meningiomas","volume":"169","author":"Ansari","year":"2020","journal-title":"Handb Clin Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111603_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006493130855","article-title":"Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling","volume":"50","author":"Patan","year":"2000","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5414\/NP300488","article-title":"Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches","volume":"31","author":"Preusser","year":"2012","journal-title":"Clin Neuropathol"},{"issue":"2","key":"10.1016\/j.jocn.2025.111603_b0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10735-020-09940-2","article-title":"Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients","volume":"52","author":"Bernatz","year":"2021","journal-title":"J Mol Histol"},{"key":"10.1016\/j.jocn.2025.111603_b0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.25259\/SNI_528_2020","article-title":"The relationship between vascular endothelial growth factor and histological grade in intracranial meningioma","volume":"11","author":"Winter","year":"2020","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jocn.2025.111603_b0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.wneu.2017.08.096","article-title":"Angiomatous meningiomas have a very benign outcome despite frequent peritumoral edema at onset","volume":"108","author":"Hua","year":"2017","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/neup.12148","article-title":"Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma","volume":"35","author":"van de Nes","year":"2015","journal-title":"Neuropathology"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0170","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.21873\/anticanres.15711","article-title":"Expression of ENO1 is up-regulated in low-grade glioma and positively correlated with meningioma grade","volume":"42","author":"Dinh","year":"2022","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3171\/jns.2001.95.5.0839","article-title":"Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema","volume":"95","author":"Nordqvist","year":"2001","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.jocn.2025.111603_b0180","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1440-1789.2012.01312.x","article-title":"Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas","volume":"32","author":"Iwado","year":"2012","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0185","first-page":"485","article-title":"Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?","volume":"20","author":"Barresi","year":"2008","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","article-title":"Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas","volume":"146","author":"Wang","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bpa.12892","article-title":"TERT promoter mutations in primary and secondary WHO grade III meningioma","volume":"31","author":"Maier","year":"2021","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0200","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3171\/2022.7.JNS22585","article-title":"Gene expression analysis during progression of malignant meningioma compared to benign meningioma","volume":"138","author":"Maier","year":"2023","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1748-717X-5-46","article-title":"Assessment of epidermal growth factor receptor (EGFR) expression in human meningioma","volume":"30","author":"Wernicke","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jocn.2025.111603_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/S1096-6374(01)80020-4","article-title":"Cancer and the potential place for growth hormone receptor antagonist therapy","volume":"11","author":"Friend","year":"2001","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0215","first-page":"16","article-title":"Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas","volume":"122","author":"Lee","year":"2013","journal-title":"J Pathol Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.jocn.2025.111603_b0220","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1600-0463.2011.02764.x","article-title":"Vascular endothelial growth factor a protein level and gene expression in intracranial meningiomas with brain edema","volume":"119","author":"Nassehi","year":"2011","journal-title":"APMIS"},{"key":"10.1016\/j.jocn.2025.111603_b0225","doi-asserted-by":"crossref","unstructured":"Reszec J, Hermanowicz A, Rutkowski R, Turek G, Mariak Z, Chyczewski L. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. Biomed Res Int. 2015;2015:646853. doi: 10.1155\/2015\/646853. Epub 2015 Mar 3. PMID: 25821815; PMCID: PMC4363610.","DOI":"10.1155\/2015\/646853"},{"year":"2007","series-title":"World Health Organization histological classification of tumours of the central nervous system","author":"Louis","key":"10.1016\/j.jocn.2025.111603_b0230"},{"key":"10.1016\/j.jocn.2025.111603_b0235","doi-asserted-by":"crossref","unstructured":"Maiuri F, Mariniello G, de Divitiis O, Esposito F, Guadagno E, Teodonno G, Barbato M, Del Basso De Caro M. Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications. Front Oncol. 2021 Jul 15;11:611218. doi: 10.3389\/fonc.2021.611218. PMID: 34336636; PMCID: PMC8320886.","DOI":"10.3389\/fonc.2021.611218"},{"key":"10.1016\/j.jocn.2025.111603_b0240","doi-asserted-by":"crossref","unstructured":"Herting B, Meixensberger J, Roggendorf W and Reichmann H: Metabolic patterns in meningiomas. J Neurooncol 65(2): 119-123, 2003. PMID: 14686730. DOI: 10.1023\/b:neon.0000003680.84840.52.","DOI":"10.1023\/B:NEON.0000003680.84840.52"},{"key":"10.1016\/j.jocn.2025.111603_b0245","doi-asserted-by":"crossref","unstructured":"Bharadwaj S, Venkatraghavan L, Mariappan R, Ebinu J, Meng Y, Khan O, Tung T, Reyhani S, Bernstein M and Zadeh G: Serum lactate as a potential biomarker of non-glial brain tumors. J Clin Neurosci 22(10): 1625-1627, 2015. PMID: 26100160. DOI: 10.1016\/j.jocn.2015.05.009.","DOI":"10.1016\/j.jocn.2015.05.009"},{"key":"10.1016\/j.jocn.2025.111603_b0250","doi-asserted-by":"crossref","unstructured":"Warburg O, Wind F and Negelein E: The metabolism of tumors in the body. J Gen Physiol 8(6): 519-530, 1927. PMID: 19872213. DOI: 10.1085\/jgp.8.6.519.","DOI":"10.1085\/jgp.8.6.519"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0255","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.21873\/anticanres.15711","article-title":"Expression of ENO1 is up-regulated in low-grade glioma and positively correlated with meningioma grade","volume":"42","author":"Dinh","year":"2022","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.jocn.2025.111603_b0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3171\/jns.2000.92.3.0401","article-title":"Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?","volume":"92","author":"Fewings","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2025.111603_b0265","doi-asserted-by":"crossref","unstructured":"Maiuri F, Mariniello G, Guadagno E, Barbato M, Corvino S, Del Basso De Caro M. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma. Acta Neurochir (Wien). 2019 Dec;161(12):2553-2561. doi: 10.1007\/s00701-019-04084-z. Epub 2019 Oct 21. PMID: 31637512.","DOI":"10.1007\/s00701-019-04084-z"},{"key":"10.1016\/j.jocn.2025.111603_b0270","doi-asserted-by":"crossref","unstructured":"Maiuri F, Mariniello G, de Divitiis O, Esposito F, Guadagno E, Teodonno G, Barbato M, Del Basso De Caro M. Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications. Front Oncol. 2021 Jul 15;11:611218. doi: 10.3389\/fonc.2021.611218. PMID: 34336636; PMCID: PMC8320886.","DOI":"10.3389\/fonc.2021.611218"},{"issue":"10","key":"10.1016\/j.jocn.2025.111603_b0275","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jcp.2004.018333","article-title":"The prognostic value of progesterone receptor status in meningiomas","volume":"57","author":"Roser","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jocn.2025.111603_b0280","doi-asserted-by":"crossref","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J et al. TERT Promoter Mutations and Risk of Recurrence in Meningioma. J Natl Cancer Inst. 2015 Dec 13;108(5):djv377. doi: 10.1093\/jnci\/djv377. PMID: 26668184; PMCID: PMC4849806.","DOI":"10.1093\/jnci\/djv377"},{"key":"10.1016\/j.jocn.2025.111603_b0285","doi-asserted-by":"crossref","unstructured":"Bostr\u00f6m J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P et al. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol. 2001 Aug;159(2):661-9. doi: 10.1016\/S0002-9440(10)61737-3. PMID: 11485924; PMCID: PMC1850553. (CDKN2 loss extremely rare in WHO1 and 2).","DOI":"10.1016\/S0002-9440(10)61737-3"},{"key":"10.1016\/j.jocn.2025.111603_b0290","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/neuonc\/noac032","article-title":"The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas","volume":"24","author":"Rebchuk","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2025.111603_b0295","doi-asserted-by":"crossref","unstructured":"Griffin RL. The Association between Medroxyprogesterone Acetate Exposure and Meningioma. Cancers (Basel). 2024;16(19).","DOI":"10.3390\/cancers16193362"},{"key":"10.1016\/j.jocn.2025.111603_b0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078078","article-title":"Use of progestogens and the risk of intracranial meningioma: national case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jocn.2025.111603_b0305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-020-03672-9","article-title":"Cyproterone acetate and meningioma: a nationwide-wide population-based study","volume":"151","author":"Champeaux-Depond","year":"2021","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0310","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1038\/s41598-021-88742-2","article-title":"The risk of developing a meningioma during and after pregnancy","volume":"11","author":"Pettersson-Segerlind","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jocn.2025.111603_b0315","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwj254","article-title":"Risk of brain tumors associated with exposure to exogenous female sex hormones","volume":"164","author":"Wigertz","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2025.111603_b0320","unstructured":"Tettamanti G, Shu X, Mogensen H, Kopp Kallner H, Mathiesen T, Maria Feychting M. Hormonal contraceptives and the risk of meningioma: a Swedish register-based case-control study."},{"key":"10.1016\/j.jocn.2025.111603_b0325","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jne.12060","article-title":"Nonclassical progesterone signalling molecules in the nervous system","volume":"25","author":"Petersen","year":"2013","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.jocn.2025.111603_b0330","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/neuonc\/noae239","article-title":"Meningiomas: sex-specific differences and prognostic implications of a chromosome X loss","volume":"27","author":"Berghaus","year":"2025","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2025.111603_b0335","doi-asserted-by":"crossref","unstructured":"Pettersson-Segerlind J, Fletcher-Sandersj\u00f6\u00f6 A, von Vogelsang AC, Persson O, Kihlstr\u00f6m Burenstam Linder L, F\u00f6rander P, Mathiesen T et al. Long-Term Follow-Up, Treatment Strategies, Functional Outcome, and Health-Related Quality of Life after Surgery for WHO Grade 2 and 3 Intracranial Meningiomas. Cancers (Basel). 2022 Oct 14;14(20):5038. doi: 10.3390\/cancers14205038. PMID: 36291821; PMCID: PMC9600120.","DOI":"10.3390\/cancers14205038"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00701-020-04650-w","article-title":"Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis","volume":"163","author":"Boetto","year":"2021","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0345","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3171\/2021.10.JNS204467","article-title":"Letter to the Editor Copenhagen grading of meningioma","volume":"136","author":"Mathiesen","year":"2022","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0350","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","article-title":"Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients A multivariate analysis","volume":"26","author":"J\u00e4\u00e4skel\u00e4inen","year":"1986","journal-title":"Surg Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111603_b0355","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3171\/2010.3.JNS091971","article-title":"The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas","volume":"113","author":"Sughrue","year":"2010","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0360","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3171\/2016.1.JNS151842","article-title":"Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma","volume":"126","author":"Nanda","year":"2017","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.jocn.2025.111603_b0365","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3171\/2012.9.JNS12294","article-title":"Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article","volume":"117","author":"Hasseleid","year":"2012","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111603_b0370","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/neuros\/nyaa355","article-title":"A Prognostic gene-expression signature and risk score for meningioma recurrence after resection","volume":"88","author":"Chen","year":"2020","journal-title":"Neurosurgery"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825005764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825005764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:10:32Z","timestamp":1762290632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825005764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":74,"alternative-id":["S0967586825005764"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111603","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations between surface marker patterns in meningiomas, prognosis and location","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111603"}}